NTN1 and colorectal cancer: However, studies of human colorectal cancers [96] have shown that only 7% of colorectal cancers have over-expression of netrin-1, implying that loss of the DCC receptor complex by 18q allelic loss or direct mutation may not confer the same selective advantage towards human colorectal cancer cells.